0.08EUR
18.33 MEUR
145.56 MEUR
210.92 M
About ADVANCED MED.SO.GRP LS-05
Sector
Industry
CEO
Andrew Christopher Meredith
Website
Headquarters
Winsford
Founded
1993
ISIN
GB0004536594
FIGI
BBG000MZL469
Advanced Medical Solutions Group Plc engages in the design, development, manufacture and distribution of wound care products, surgical dressings, medical grade materials, and medical adhesives and sutures for closing and sealing tissue. It operates through the Surgical and Woundcare segments. The Surgical segment includes the sales, marketing, research, development, and innovation of all surgical products. The Woundcare segment include all advanced woundcare sales, marketing, research, development, and innovation of all woundcare devices, regardless of whether they are sold under an AMS or a partner brand name. The company was founded in 1991 and is headquartered in Winsford, the United Kingdom.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of AQA is 2.20 EUR — it has increased by 0.92% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange ADVANCED MED.SO.GRP LS-05 stocks are traded under the ticker AQA.
ADVANCED MED.SO.GRP LS-05 is going to release the next earnings report on Sep 11, 2024. Keep track of upcoming events with our Earnings Calendar.
AQA stock is 0.91% volatile and has beta coefficient of 0.83. Check out the list of the most volatile stocks — is ADVANCED MED.SO.GRP LS-05 there?
AQA earnings for the last quarter are 0.06 EUR per share, whereas the estimation was 0.06 EUR resulting in a −0.60% surprise. The estimated earnings for the next quarter are 0.05 EUR per share. See more details about ADVANCED MED.SO.GRP LS-05 earnings.
ADVANCED MED.SO.GRP LS-05 revenue for the last quarter amounts to 73.42 M EUR despite the estimated figure of 70.96 M EUR. In the next quarter revenue is expected to reach 72.08 M EUR.
Yes, you can track ADVANCED MED.SO.GRP LS-05 financials in yearly and quarterly reports right on TradingView.
AQA stock has risen by 2.80% compared to the previous week, the month change is a 2.80% rise, over the last year ADVANCED MED.SO.GRP LS-05 has showed a 19.12% decrease.
AQA net income for the last quarter is 8.02 M EUR, while the quarter before that showed 10.39 M EUR of net income which accounts for −22.80% change. Track more ADVANCED MED.SO.GRP LS-05 financial stats to get the full picture.
Today ADVANCED MED.SO.GRP LS-05 has the market capitalization of 485.53 M, it has increased by 2.13% over the last week.
ADVANCED MED.SO.GRP LS-05 dividend yield was 1.14% in 2023, and payout ratio reached 32.07%. The year before the numbers were 0.83% and 22.82% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, AQA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ADVANCED MED.SO.GRP LS-05 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ADVANCED MED.SO.GRP LS-05 technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ADVANCED MED.SO.GRP LS-05 stock shows the sell signal. See more of ADVANCED MED.SO.GRP LS-05 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on ADVANCED MED.SO.GRP LS-05 future price: according to them, AQA price has a max estimate of 3.80 EUR and a min estimate of 2.51 EUR. Read a more detailed ADVANCED MED.SO.GRP LS-05 forecast: see what analysts think of ADVANCED MED.SO.GRP LS-05 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ADVANCED MED.SO.GRP LS-05 EBITDA is 33.15 M EUR, and current EBITDA margin is 24.32%. See more stats in ADVANCED MED.SO.GRP LS-05 financial statements.